Open AccessLetter to the editor: BET inhibitors might target innate inflammatory and profibrotic signaling networks in COPD
Author(s) -
Jing Du,
Yong Han
Publication year - 2017
Publication title -
ajp lung cellular and molecular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.892
H-Index - 163
eISSN - 1522-1504
pISSN - 1040-0605
DOI - 10.1152/ajplung.00246.2017
Subject(s) - copd , china , medicine , bromodomain , gene , bioinformatics , epigenetics , biology , political science , genetics , law
to the editor: Establishing new therapeutic approaches for patients with heart failure (HF) is of crucial importance. In a recent article from Science Translational Medicine , Duan et al. ([1][1]) demonstrated that bromodomain and extra-terminal motif (BET) bromodomain inhibitor JQ1 could treat HF
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom